Gilead Sciences price target raised to $170 by JPMorgan
JP Morgan raised its price target on Gilead Sciences to $170.00 per share from $160.00, according to Benzinga’s ratings coverage.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.